How to go abroad?

[pharmaceutical network market analysis] Traditional Chinese medicine is an important part of China's pharmaceutical industry, and it is also the civilization inheritance of the Chinese nation for thousands of years In recent years, with the support of "healthy China 2030" program and other policies, Chinese traditional medicine industry has developed rapidly Data shows that Chinese traditional medicine industry has developed rapidly in the past 20 years, and the income of Enterprises above the scale of traditional Chinese medicine may reach 1582.3 billion yuan in 2020 In terms of market scale, it is estimated that the market scale of Chinese traditional medicine will reach 537.6 billion yuan in 2019, and the sales volume of Chinese traditional medicine market will account for 32.4% of the whole pharmaceutical market in 2020 However, with the further promotion of medical insurance fee control, key monitoring drug catalog and other measures, China's traditional Chinese medicine industry is also facing tremendous pressure of transformation and upgrading At present, many traditional Chinese medicine enterprises will continue to push the traditional Chinese medicine industry into the era of intelligent manufacturing, hoping to use modern scientific and technological means to deconstruct the systematization and complexity of traditional Chinese medicine, clarify the connotation of safety, effectiveness and quality control of traditional Chinese medicine products, so as to improve the quality of traditional Chinese medicine In addition, the current Chinese medicine enterprises also face an important issue is how to go abroad? Policies and regulations If Chinese medicine enterprises want to go out, legal protection is indispensable In recent years, driven by a series of favorable policies, Chinese medicine enterprises have more say In recent years, many provinces and cities have also given some support to Chinese medicine enterprises to go out For example, one belt, one road, is to encourage Chinese medicine, health products and food additives to go abroad Gansu will support overseas exhibitions that are organized by the unified organization or the key exhibitions in the province Chinese medicine enterprises go out and burn real gold and silver It is reported that some Chinese medicine enterprises have invested more than 100 million yuan to go global If we want to successfully list in the main foreign pharmaceutical markets, we need to wait for at least 5-8 years, and invest about 600-800 million yuan In addition, the key point is that traditional Chinese medicine needs innovation and development, and enterprises need to combine traditional Chinese medicine with modernization In the view of some Chinese medicine entrepreneurs, if Chinese medicine can realize going out, it means that a certain treatment method of Chinese medicine is essentially recognized by the world The concept of pharmacy in Chinese and Western medicine belongs to two different theoretical systems Therefore, traditional Chinese medicine enterprises need to use modern experimental technology to prove that the quality of traditional Chinese medicine is controllable, safe and effective For example, Tianshili's Compound Danshen dropping pill is a product produced by integrating modern technology In September 2018, Tianshili and American pharmaceutical company arbor announced a comprehensive cooperation on the R & D and marketing of T89 (Compound Danshen dropping pill) in the United States, which will help the traditional Chinese medicine product move to the international stage It is understood that Tianshili has also innovated and built the production line of micro drop pills and digital intelligent extraction production line of traditional Chinese medicine by promoting the intelligent manufacturing of modern traditional Chinese medicine, realizing the new leap of intelligent manufacturing of traditional Chinese medicine in the aspects of large-scale extraction of traditional Chinese medicine, production system of drop pills and traditional Chinese medicine injection In an interview with the media, the relevant head of Tianshili said that traditional Chinese medicine enterprises are facing such problems as the level of pharmaceutical technology has not yet been internationalized, the enterprise's international production capacity and quality control system are not perfect, the R & D cycle is long, and the fund is insufficient It is a prerequisite for enterprises to go abroad to make full use of policy advantages and actively accept the supervision and inspection of drug quality by foreign institutions At present, our traditional Chinese medicine industry is still characterized by small scale, large number of production enterprises and scattered products Generally speaking, it is a long process for Chinese medicine to go out, which needs the support of policy, and encourages Chinese medicine enterprises to go abroad At the same time, Chinese medicine enterprises also need to continuously inject modern science and technology, find the right position, and serve more people.